BugSee provides a kit‑based pre‑analytical platform that removes blood cells and plasma from blood culture samples, delivering a pathogen‑enriched specimen ready for culture, MALDI‑TOF, or molecular testing. The chemistry works with Gram‑positive, Gram‑negative bacteria and yeasts and integrates with standard lab equipment, cutting hands‑on processing time by up to 80 minutes and accelerating time‑to‑identification for clinical microbiology labs.
Funding
Funding not disclosed
Founders
Product
Problem
Sepsis diagnosis relies on blood cultures that require extensive manual preparation to remove blood components while preserving viable pathogens. The pre‑analytical step consumes roughly 80 minutes of hands‑on time per sample, limiting throughput and delaying pathogen identification and antimicrobial susceptibility testing. Consequently, laboratories struggle to deliver timely results, especially in resource‑constrained settings.
Solution
BugSee offers a pre‑analytical sample‑preparation platform that rapidly clears background blood cells and plasma, delivering a pathogen‑enriched, culture‑ready specimen without the need for additional instrumentation. The kits employ a proprietary chemical‑physical separation process that preserves viable bacteria and yeasts, enabling downstream identification and susceptibility workflows to proceed immediately. Because the workflow integrates with standard laboratory equipment (e.g., centrifuges, incubators), labs can adopt the solution without altering existing SOPs or investing in new hardware. The streamlined protocol reduces hands‑on time, accelerates time‑to‑identification, and supports earlier initiation of targeted antimicrobial therapy, improving patient outcomes while maintaining cost efficiency.
Target Audience
The primary customers are clinical microbiology laboratories in hospitals and diagnostic centers that process blood cultures for sepsis, including both high‑throughput academic labs and smaller, resource‑constrained facilities.
Features
- Pathogen‑agnostic chemistry that works with Gram‑positive, Gram‑negative bacteria and yeasts, ensuring no limitation on organism type
- Compatibility with common lab instruments (centrifuges, incubators, biosafety cabinets)
- no dedicated device required
- Rapid background clearance (blood cell and plasma removal) completed in minutes, preserving organism viability for culture, MALDI‑TOF, or molecular assays
- Simple, kit‑based workflow with minimal hands‑on steps, reducing technician time per sample by up to 80 minutes
- Seamless integration into existing microbiology SOPs; no software or data‑management changes needed
- Scalable batch processing for high‑throughput labs while remaining practical for low‑volume, resource‑limited settings
- Quality‑controlled reagents packaged for consistent performance across batches and laboratories